Kodiak Sciences, Inc. (KOD)
27.72
+1.10
(+4.13%)
USD |
NASDAQ |
Jan 09, 16:00
27.60
-0.12
(-0.43%)
After-Hours: 20:00
Kodiak Sciences Shareholders Equity (Quarterly): 23.69M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Cytokinetics, Inc. | -521.12M |
| Amicus Therapeutics, Inc. | 230.42M |
| Ionis Pharmaceuticals, Inc. | 617.97M |
| ADMA Biologics, Inc. | 431.19M |
| Arcutis Biotherapeutics, Inc. | 158.07M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 218.07M |
| Total Liabilities (Quarterly) | 194.38M |
| Debt to Equity Ratio | 6.846 |
| Current Ratio | 1.785 |
| Net Debt Paydown Yield | 0.31% |